Details for: TPM2

Gene ID: 7169

Gene Type:  Protein-coding  - A gene that serves as a template for producing a messenger RNA (mRNA) molecule, which is then translated into a functional protein.

Symbol: TPM2

Ensembl ID: ENSG00000198467

Description: tropomyosin 2

Selected Context(s):  Overall

Cell Significance Landscape

Contexts:

Associated with

Significant Cells

Cell Significance Index (CSI) scores for the chosen context(s)

  • enteric smooth muscle cell CL0002504
    CSI 41.86
    rCSI 59.74%
    PRS 88.22
  • myofibroblast cell CL0000186
    CSI 40.78
    rCSI 56.48%
    PRS 84.43
  • bronchus fibroblast of lung CL2000093
    CSI 40.36
    rCSI 32.79%
    PRS 87.23
  • secretory cell CL0000151
    CSI 39.37
    rCSI 41.08%
    PRS 86.8
  • muscle cell CL0000187
    CSI 36.89
    rCSI 75.75%
    PRS 92.16
  • myoepithelial cell CL0000185
    CSI 31.74
    rCSI 80.3%
    PRS 90.89
  • interstitial cell of Cajal CL0002088
    CSI 31.51
    rCSI 40.11%
    PRS 91.83
  • plasmacytoid dendritic cell, human CL0001058
    CSI 30.85
    rCSI 21.54%
    PRS 91.16
  • smooth muscle cell CL0000192
    CSI 30.8
    rCSI 73.44%
    PRS 82.71
  • tracheobronchial smooth muscle cell CL0019019
    CSI 26.89
    rCSI 47.42%
    PRS 91
  • mesodermal cell CL0000222
    CSI 23.58
    rCSI 28.3%
    PRS 86.62
  • fallopian tube secretory epithelial cell CL4030006
    CSI 21.58
    rCSI 20.78%
    PRS 86.82
  • basal-myoepithelial cell of mammary gland CL0002324
    CSI 21.07
    rCSI 39.83%
    PRS 94
  • vascular associated smooth muscle cell CL0000359
    CSI 20.51
    rCSI 66.54%
    PRS 85.85
  • stromal cell of ovary CL0002132
    CSI 18.29
    rCSI 50.27%
    PRS 91.66
  • glioblast CL0000030
    CSI 18.11
    rCSI 28.89%
    PRS 80.13
  • fibroblast of lung CL0002553
    CSI 17.97
    rCSI 16.73%
    PRS 88.94
  • neural crest cell CL0011012
    CSI 17.52
    rCSI 13.85%
    PRS 79.64
  • microcirculation associated smooth muscle cell CL0008035
    CSI 17.44
    rCSI 50.5%
    PRS 87.01
  • epithelial cell of lower respiratory tract CL0002632
    CSI 16.92
    rCSI 13.11%
    PRS 90.9
  • blood vessel endothelial cell CL0000071
    CSI 16.88
    rCSI 35.03%
    PRS 85.71
  • plasmacytoid dendritic cell CL0000784
    CSI 15.82
    rCSI 16.03%
    PRS 94.44
  • lung pericyte CL0009089
    CSI 15.25
    rCSI 40.25%
    PRS 92.27
  • fast muscle cell CL0000190
    CSI 14.95
    rCSI 58.43%
    PRS 81.64
  • radial glial cell CL0000681
    CSI 13.63
    rCSI 18.94%
    PRS 86.34
  • Schwann cell CL0002573
    CSI 12.08
    rCSI 34.33%
    PRS 83.86
  • mesenchymal cell CL0008019
    CSI 12.08
    rCSI 30.67%
    PRS 82.34
  • stromal cell CL0000499
    CSI 11.92
    rCSI 33.55%
    PRS 83.55
  • megakaryocyte-erythroid progenitor cell CL0000050
    CSI 11.76
    rCSI 10.62%
    PRS 86.68
  • stem cell CL0000034
    CSI 11.43
    rCSI 11.02%
    PRS 83.18
  • alveolar type 1 fibroblast cell CL4028004
    CSI 11.3
    rCSI 12.38%
    PRS 89.36
  • ciliated cell CL0000064
    CSI 11.01
    rCSI 17.83%
    PRS 82.35
  • skin fibroblast CL0002620
    CSI 11.01
    rCSI 9.49%
    PRS 87.47
  • mucous neck cell CL0000651
    CSI 10.85
    rCSI 15.64%
    PRS 91.45
  • dendritic cell CL0000451
    CSI 10.83
    rCSI 13.35%
    PRS 88.17
  • CD8-positive, alpha-beta memory T cell, CD45RO-positive CL0001203
    CSI 10.75
    rCSI 13.03%
    PRS 68.43
  • respiratory basal cell CL0002633
    CSI 10.69
    rCSI 11.07%
    PRS 90
  • regulatory T cell CL0000815
    CSI 10.58
    rCSI 12.26%
    PRS 83.91
  • melanocyte of skin CL1000458
    CSI 10.47
    rCSI 14.27%
    PRS 57.22
  • pulmonary artery endothelial cell CL1001568
    CSI 9.84
    rCSI 13.39%
    PRS 93.1
  • ventricular cardiac muscle cell CL2000046
    CSI 9.7
    rCSI 33.24%
    PRS 91.73
  • pro-B cell CL0000826
    CSI 9.65
    rCSI 7.99%
    PRS 89.88
  • neuroblast (sensu Nematoda and Protostomia) CL0000338
    CSI 9.65
    rCSI 11.14%
    PRS 80.65
  • early lymphoid progenitor CL0000936
    CSI 9.42
    rCSI 8.27%
    PRS 91.62
  • pericyte CL0000669
    CSI 9.37
    rCSI 24.94%
    PRS 64.46
  • pancreatic stellate cell CL0002410
    CSI 9.34
    rCSI 54.33%
    PRS 89.84
  • fibroblast of breast CL4006000
    CSI 8.83
    rCSI 37.13%
    PRS 90.46
  • promyelocyte CL0000836
    CSI 8.74
    rCSI 12.6%
    PRS 90.99
  • contractile cell CL0000183
    CSI 8.73
    rCSI 25.77%
    PRS 86.89
  • ciliated columnar cell of tracheobronchial tree CL0002145
    CSI 8.66
    rCSI 19.73%
    PRS 80.95
  • mononuclear phagocyte CL0000113
    CSI 8.08
    rCSI 17.78%
    PRS 90.5
  • perivascular cell CL4033054
    CSI 7.89
    rCSI 10.79%
    PRS 91.16
  • peripheral nervous system neuron CL2000032
    CSI 7.72
    rCSI 10.52%
    PRS 81.15
  • adventitial cell CL0002503
    CSI 7.66
    rCSI 18.28%
    PRS 90.38
  • respiratory suprabasal cell CL4033048
    CSI 7.6
    rCSI 9.75%
    PRS 89.82
  • myeloid leukocyte CL0000766
    CSI 7.54
    rCSI 6.96%
    PRS 88.97
  • parietal epithelial cell CL1000452
    CSI 6.93
    rCSI 18.51%
    PRS 81.53
  • multi-ciliated epithelial cell CL0005012
    CSI 6.84
    rCSI 6.82%
    PRS 82.16
  • chondrocyte CL0000138
    CSI 6.76
    rCSI 10.76%
    PRS 82.51
  • alveolar adventitial fibroblast CL4028006
    CSI 6.74
    rCSI 10.65%
    PRS 88.75
  • regular atrial cardiac myocyte CL0002129
    CSI 6.72
    rCSI 21.64%
    PRS 84.56
  • cardiac endothelial cell CL0010008
    CSI 6.64
    rCSI 26.79%
    PRS 88.33
  • forebrain radial glial cell CL0013000
    CSI 6.53
    rCSI 20.96%
    PRS 88.07
  • adipocyte CL0000136
    CSI 6.42
    rCSI 8.24%
    PRS 78.94
  • skeletal muscle satellite cell CL0000594
    CSI 6.42
    rCSI 18.76%
    PRS 94.25
  • hepatic stellate cell CL0000632
    CSI 6.4
    rCSI 23.96%
    PRS 82.37
  • podocyte CL0000653
    CSI 6.39
    rCSI 28.41%
    PRS 88.59
  • lung ciliated cell CL1000271
    CSI 6.27
    rCSI 7.25%
    PRS 81.75
  • blood vessel smooth muscle cell CL0019018
    CSI 6.11
    rCSI 49.73%
    PRS 83.92
  • common lymphoid progenitor CL0000051
    CSI 6.1
    rCSI 8.16%
    PRS 96.83
  • tendon cell CL0000388
    CSI 6.1
    rCSI 15.86%
    PRS 91.82
  • fibroblast CL0000057
    CSI 5.68
    rCSI 16.35%
    PRS 79.4
  • respiratory hillock cell CL4030023
    CSI 5.63
    rCSI 10.04%
    PRS 92.59
  • glial cell CL0000125
    CSI 5.53
    rCSI 21.04%
    PRS 80.65
  • innate lymphoid cell CL0001065
    CSI 5.42
    rCSI 11.19%
    PRS 82.84
  • endocardial cell CL0002350
    CSI 5.26
    rCSI 25.19%
    PRS 83.89
  • basal cell CL0000646
    CSI 5.18
    rCSI 6.93%
    PRS 85.37
  • helper T cell CL0000912
    CSI 4.97
    rCSI 7.03%
    PRS 84.54
  • choroid plexus epithelial cell CL0000706
    CSI 4.94
    rCSI 8.1%
    PRS 79.76
  • renal interstitial pericyte CL1001318
    CSI 4.87
    rCSI 13.43%
    PRS 84.48
  • nasal mucosa goblet cell CL0002480
    CSI 4.67
    rCSI 5.42%
    PRS 89.12
  • intestine goblet cell CL0019031
    CSI 4.62
    rCSI 4.1%
    PRS 85.34
  • cardiac muscle cell CL0000746
    CSI 4.55
    rCSI 6.52%
    PRS 79.34
  • hematopoietic stem cell CL0000037
    CSI 4.45
    rCSI 2.95%
    PRS 89.78
  • megakaryocyte CL0000556
    CSI 4.19
    rCSI 18.18%
    PRS 90.28
  • cerebral cortex endothelial cell CL1001602
    CSI 4.18
    rCSI 7.24%
    PRS 81.58
  • basal cell of prostate epithelium CL0002341
    CSI 4.12
    rCSI 11.92%
    PRS 91.55
  • bronchiolar smooth muscle cell CL4033017
    CSI 3.92
    rCSI 58.89%
    PRS 92.82
  • astrocyte of the cerebral cortex CL0002605
    CSI 3.78
    rCSI 8.47%
    PRS 73.97
  • intestinal tuft cell CL0019032
    CSI 3.74
    rCSI 5.72%
    PRS 90.26
  • fraction A pre-pro B cell CL0002045
    CSI 3.65
    rCSI 4.18%
    PRS 93.44
  • retinal blood vessel endothelial cell CL0002585
    CSI 3.45
    rCSI 5.51%
    PRS 90.83
  • kidney interstitial cell CL1000500
    CSI 3.44
    rCSI 56.45%
    PRS 89.79
  • slow muscle cell CL0000189
    CSI 3.24
    rCSI 43.18%
    PRS 82.66
  • brush cell CL0002204
    CSI 3.24
    rCSI 6.4%
    PRS 92
  • mesenchymal stem cell of adipose tissue CL0002570
    CSI 3.23
    rCSI 18.01%
    PRS 89.06
  • epicardial adipocyte CL1000309
    CSI 3.12
    rCSI 10.16%
    PRS 85.04
  • basal cell of epidermis CL0002187
    CSI 3.09
    rCSI 5.48%
    PRS 58.3
  • brain vascular cell CL4023072
    CSI 3.08
    rCSI 31.86%
    PRS 81.85
  • cell of skeletal muscle CL0000188
    CSI 3.06
    rCSI 33.24%
    PRS 89.97
  • respiratory goblet cell CL0002370
    CSI 0.4
    rCSI 4.6%
    PRS 91.8%
  • vein endothelial cell of respiratory system CL4033008
    CSI 0.6
    rCSI 4.4%
    PRS 91.7%
  • osteoblast CL0000062
    CSI 0.6
    rCSI 15.8%
    PRS 94.9%
  • kidney granular cell CL0000648
    CSI 0.8
    rCSI 11.0%
    PRS 89.3%
  • tracheobronchial serous cell CL0019001
    CSI 0.8
    rCSI 3.4%
    PRS 91.3%
  • follicular dendritic cell CL0000442
    CSI 0.8
    rCSI 13.4%
    PRS 93.0%
  • peptic cell CL0000155
    CSI 0.9
    rCSI 8.8%
    PRS 93.2%
  • bronchial goblet cell CL1000312
    CSI 1.0
    rCSI 4.1%
    PRS 92.0%
  • endothelial cell of uterus CL0009095
    CSI 1.1
    rCSI 7.8%
    PRS 93.0%
  • pluripotent stem cell CL0002248
    CSI 1.1
    rCSI 32.2%
    PRS 93.7%
  • regular ventricular cardiac myocyte CL0002131
    CSI 1.3
    rCSI 7.8%
    PRS 81.0%
  • lymphoid lineage restricted progenitor cell CL0000838
    CSI 1.4
    rCSI 5.3%
    PRS 96.9%
  • keratocyte CL0002363
    CSI 1.4
    rCSI 3.4%
    PRS 89.3%
  • pulmonary alveolar type 1 cell CL0002062
    CSI 1.5
    rCSI 8.7%
    PRS 84.6%
  • lung microvascular endothelial cell CL2000016
    CSI 1.6
    rCSI 30.8%
    PRS 92.9%
  • mesenchymal stem cell CL0000134
    CSI 1.6
    rCSI 17.9%
    PRS 90.5%
  • common dendritic progenitor CL0001029
    CSI 1.7
    rCSI 2.1%
    PRS 93.6%
  • mesangial cell CL0000650
    CSI 1.7
    rCSI 6.9%
    PRS 93.4%
  • mesenchymal lymphangioblast CL0005021
    CSI 1.8
    rCSI 46.7%
    PRS 91.9%
  • basal cell of epithelium of trachea CL1000348
    CSI 1.8
    rCSI 12.7%
    PRS 89.7%
  • duct epithelial cell CL0000068
    CSI 1.9
    rCSI 2.7%
    PRS 91.6%
  • skeletal muscle satellite stem cell CL0008011
    CSI 1.9
    rCSI 8.6%
    PRS 94.0%
  • primordial germ cell CL0000670
    CSI 1.9
    rCSI 9.7%
    PRS 94.1%
  • granulocyte CL0000094
    CSI 1.9
    rCSI 3.0%
    PRS 92.8%
  • foveolar cell of stomach CL0002179
    CSI 2.0
    rCSI 4.2%
    PRS 90.8%
  • erythroblast CL0000765
    CSI 2.1
    rCSI 5.5%
    PRS 90.2%
  • suprabasal keratinocyte CL4033013
    CSI 2.1
    rCSI 3.4%
    PRS 57.4%
  • large pre-B-II cell CL0000957
    CSI 2.5
    rCSI 7.2%
    PRS 89.8%
  • cytotoxic T cell CL0000910
    CSI 2.6
    rCSI 14.7%
    PRS 88.1%
  • common myeloid progenitor CL0000049
    CSI 2.8
    rCSI 2.2%
    PRS 89.6%
  • extravillous trophoblast CL0008036
    CSI 2.8
    rCSI 3.5%
    PRS 86.3%
  • mammary gland epithelial cell CL0002327
    CSI 3.1
    rCSI 10.7%
    PRS 92.6%
  • cell of skeletal muscle CL0000188
    CSI 3.1
    rCSI 33.2%
    PRS 90.0%
  • brain vascular cell CL4023072
    CSI 3.1
    rCSI 31.9%
    PRS 81.9%
  • basal cell of epidermis CL0002187
    CSI 3.1
    rCSI 5.5%
    PRS 58.3%
  • epicardial adipocyte CL1000309
    CSI 3.1
    rCSI 10.2%
    PRS 85.0%
  • mesenchymal stem cell of adipose tissue CL0002570
    CSI 3.2
    rCSI 18.0%
    PRS 89.1%
  • brush cell CL0002204
    CSI 3.2
    rCSI 6.4%
    PRS 92.0%
  • slow muscle cell CL0000189
    CSI 3.2
    rCSI 43.2%
    PRS 82.7%
  • kidney interstitial cell CL1000500
    CSI 3.4
    rCSI 56.5%
    PRS 89.8%
  • retinal blood vessel endothelial cell CL0002585
    CSI 3.5
    rCSI 5.5%
    PRS 90.8%
  • fraction A pre-pro B cell CL0002045
    CSI 3.7
    rCSI 4.2%
    PRS 93.4%
  • intestinal tuft cell CL0019032
    CSI 3.7
    rCSI 5.7%
    PRS 90.3%
  • astrocyte of the cerebral cortex CL0002605
    CSI 3.8
    rCSI 8.5%
    PRS 74.0%
  • bronchiolar smooth muscle cell CL4033017
    CSI 3.9
    rCSI 58.9%
    PRS 92.8%
  • basal cell of prostate epithelium CL0002341
    CSI 4.1
    rCSI 11.9%
    PRS 91.6%
  • cerebral cortex endothelial cell CL1001602
    CSI 4.2
    rCSI 7.2%
    PRS 81.6%
  • megakaryocyte CL0000556
    CSI 4.2
    rCSI 18.2%
    PRS 90.3%
  • hematopoietic stem cell CL0000037
    CSI 4.5
    rCSI 3.0%
    PRS 89.8%
  • cardiac muscle cell CL0000746
    CSI 4.6
    rCSI 6.5%
    PRS 79.3%
  • intestine goblet cell CL0019031
    CSI 4.6
    rCSI 4.1%
    PRS 85.3%
  • nasal mucosa goblet cell CL0002480
    CSI 4.7
    rCSI 5.4%
    PRS 89.1%
  • renal interstitial pericyte CL1001318
    CSI 4.9
    rCSI 13.4%
    PRS 84.5%
  • choroid plexus epithelial cell CL0000706
    CSI 4.9
    rCSI 8.1%
    PRS 79.8%
  • helper T cell CL0000912
    CSI 5.0
    rCSI 7.0%
    PRS 84.5%
  • basal cell CL0000646
    CSI 5.2
    rCSI 6.9%
    PRS 85.4%
  • endocardial cell CL0002350
    CSI 5.3
    rCSI 25.2%
    PRS 83.9%
  • innate lymphoid cell CL0001065
    CSI 5.4
    rCSI 11.2%
    PRS 82.8%
  • glial cell CL0000125
    CSI 5.5
    rCSI 21.0%
    PRS 80.7%
  • respiratory hillock cell CL4030023
    CSI 5.6
    rCSI 10.0%
    PRS 92.6%
  • fibroblast CL0000057
    CSI 5.7
    rCSI 16.4%
    PRS 79.4%
  • tendon cell CL0000388
    CSI 6.1
    rCSI 15.9%
    PRS 91.8%
  • common lymphoid progenitor CL0000051
    CSI 6.1
    rCSI 8.2%
    PRS 96.8%
  • blood vessel smooth muscle cell CL0019018
    CSI 6.1
    rCSI 49.7%
    PRS 83.9%
  • lung ciliated cell CL1000271
    CSI 6.3
    rCSI 7.3%
    PRS 81.8%
  • podocyte CL0000653
    CSI 6.4
    rCSI 28.4%
    PRS 88.6%
  • hepatic stellate cell CL0000632
    CSI 6.4
    rCSI 24.0%
    PRS 82.4%
  • skeletal muscle satellite cell CL0000594
    CSI 6.4
    rCSI 18.8%
    PRS 94.3%
  • adipocyte CL0000136
    CSI 6.4
    rCSI 8.2%
    PRS 78.9%
  • forebrain radial glial cell CL0013000
    CSI 6.5
    rCSI 21.0%
    PRS 88.1%
  • cardiac endothelial cell CL0010008
    CSI 6.6
    rCSI 26.8%
    PRS 88.3%
  • regular atrial cardiac myocyte CL0002129
    CSI 6.7
    rCSI 21.6%
    PRS 84.6%
  • alveolar adventitial fibroblast CL4028006
    CSI 6.7
    rCSI 10.7%
    PRS 88.8%
  • chondrocyte CL0000138
    CSI 6.8
    rCSI 10.8%
    PRS 82.5%
  • multi-ciliated epithelial cell CL0005012
    CSI 6.8
    rCSI 6.8%
    PRS 82.2%
  • parietal epithelial cell CL1000452
    CSI 6.9
    rCSI 18.5%
    PRS 81.5%
  • myeloid leukocyte CL0000766
    CSI 7.5
    rCSI 7.0%
    PRS 89.0%
  • respiratory suprabasal cell CL4033048
    CSI 7.6
    rCSI 9.8%
    PRS 89.8%
  • adventitial cell CL0002503
    CSI 7.7
    rCSI 18.3%
    PRS 90.4%
  • peripheral nervous system neuron CL2000032
    CSI 7.7
    rCSI 10.5%
    PRS 81.2%
  • perivascular cell CL4033054
    CSI 7.9
    rCSI 10.8%
    PRS 91.2%
  • mononuclear phagocyte CL0000113
    CSI 8.1
    rCSI 17.8%
    PRS 90.5%
  • ciliated columnar cell of tracheobronchial tree CL0002145
    CSI 8.7
    rCSI 19.7%
    PRS 81.0%
  • contractile cell CL0000183
    CSI 8.7
    rCSI 25.8%
    PRS 86.9%
  • promyelocyte CL0000836
    CSI 8.7
    rCSI 12.6%
    PRS 91.0%
  • fibroblast of breast CL4006000
    CSI 8.8
    rCSI 37.1%
    PRS 90.5%
  • pancreatic stellate cell CL0002410
    CSI 9.3
    rCSI 54.3%
    PRS 89.8%
  • pericyte CL0000669
    CSI 9.4
    rCSI 24.9%
    PRS 64.5%
  • early lymphoid progenitor CL0000936
    CSI 9.4
    rCSI 8.3%
    PRS 91.6%
  • neuroblast (sensu Nematoda and Protostomia) CL0000338
    CSI 9.7
    rCSI 11.1%
    PRS 80.7%
  • pro-B cell CL0000826
    CSI 9.7
    rCSI 8.0%
    PRS 89.9%
  • ventricular cardiac muscle cell CL2000046
    CSI 9.7
    rCSI 33.2%
    PRS 91.7%
  • pulmonary artery endothelial cell CL1001568
    CSI 9.8
    rCSI 13.4%
    PRS 93.1%
  • melanocyte of skin CL1000458
    CSI 10.5
    rCSI 14.3%
    PRS 57.2%
  • regulatory T cell CL0000815
    CSI 10.6
    rCSI 12.3%
    PRS 83.9%
  • respiratory basal cell CL0002633
    CSI 10.7
    rCSI 11.1%
    PRS 90.0%
  • CD8-positive, alpha-beta memory T cell, CD45RO-positive CL0001203
    CSI 10.8
    rCSI 13.0%
    PRS 68.4%
  • dendritic cell CL0000451
    CSI 10.8
    rCSI 13.4%
    PRS 88.2%
  • mucous neck cell CL0000651
    CSI 10.9
    rCSI 15.6%
    PRS 91.5%
  • skin fibroblast CL0002620
    CSI 11.0
    rCSI 9.5%
    PRS 87.5%

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration

Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.

Comma-separated if multiple.
Comma-separated if multiple.

Legend:
  • Query Gene
  • Node Color (Target Cell CSI, relative to current network):
    • Very High
    • High
    • Medium
    • Low
    • Very Low
    • CSI N/A
  • Node Size: Proportional to Target Cell CSI magnitude
  • STRING PPI Edge
  • Shared Pathway Edge (ONTOLOGY)

Loading network (please wait)...

Other Information

This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.

## Summary [TPM2](/details-gene/7169) (Tropomyosin 2) encodes the beta chain of tropomyosin, a highly conserved, actin-binding protein that plays a central role in the regulation of muscle contraction and the stabilization of actin filaments in both muscle and non-muscle cells. **Overall**, expression data reveals that [TPM2](/details-gene/7169) is a defining marker for a range of contractile cell types, including various [smooth muscle cells](/details-cell/CL0000192), [myofibroblasts](/details-cell/CL0000186), and [myoepithelial cells](/details-cell/CL0000185). Its function is integral to the formation of the thin filament of the sarcomere in striated muscles and the stress fibers in non-muscle cells. Clinically, mutations in [TPM2](/details-gene/7169) are associated with several congenital myopathies and distal arthrogryposis syndromes ([108120](https://omim.org/entry/108120), [190990](https://omim.org/entry/190990)), underscoring its essential role in musculoskeletal development and function ([Link](https://doi.org/10.1016/s0960-8966(01)00252-8)). ## Cellular Roles and Expression Landscape The expression profile of [TPM2](/details-gene/7169) firmly establishes its identity as a key component of the cellular contractile apparatus. **Overall**, it exhibits the highest significance in cells defined by their contractile or structural-regulatory functions. The top-ranked cell types include [enteric smooth muscle cell](/details-cell/CL0002504) (CSI: 41.86), [myofibroblast cell](/details-cell/CL0000186) (CSI: 40.78), and [muscle cell](/details-cell/CL0000187) (CSI: 36.89). This pattern extends to other specialized contractile cells such as [myoepithelial cell](/details-cell/CL0000185) and [vascular associated smooth muscle cell](/details-cell/CL0000359), highlighting a widespread role in maintaining tone and generating force in diverse tissues. Beyond canonical muscle lineages, the high significance of [TPM2](/details-gene/7169) in [bronchus fibroblast of lung](/details-cell/CL2000093) and [myofibroblast cell](/details-cell/CL0000186) is consistent with the known function of these cells in wound healing and tissue remodeling, processes that depend on actin-myosin contractility. Early studies confirmed that a muscle-type tropomyosin is indeed expressed in fibroblasts via alternative splicing mechanisms ([Link](https://doi.org/10.1073/pnas.82.23.7835)). Interestingly, [TPM2](/details-gene/7169) also shows significant expression in less expected cell types, such as [secretory cell](/details-cell/CL0000151) and [plasmacytoid dendritic cell, human](/details-cell/CL0001058). This suggests a broader role for [TPM2](/details-gene/7169) in regulating actin cytoskeleton dynamics for processes beyond simple contraction, such as vesicle transport, cell migration, or immune surveillance. ## Pathways and Molecular Function The functional annotations for [TPM2](/details-gene/7169) align perfectly with its observed expression pattern in contractile cells. The gene product is a core participant in the '[Muscle contraction](/details-gene/R-HSA-397014)' pathway, including both '[Smooth muscle contraction](/details-gene/R-HSA-445355)' and '[Striated muscle contraction](/details-gene/R-HSA-390522)'. This is reflected in its high significance in cell types like [enteric smooth muscle cell](/details-cell/CL0002504) and [muscle cell](/details-cell/CL0000187). From a molecular standpoint, its functions are dominated by '[Actin binding](/details-gene/GO:0003779)' and its role as a '[Structural constituent of muscle](/details-gene/GO:0008307)'. Biologically, these molecular interactions drive processes like '[Actin filament organization](/details-gene/GO:0007015)' and '[Muscle contraction](/details-gene/GO:0006936)'. These annotations explain its importance not only in muscle but also in cells like [myofibroblasts](/details-cell/CL0000186), where organized actin filaments (stress fibers) are essential for generating contractile force. Its cellular localization to the '[Actin cytoskeleton](/details-gene/GO:0015629)' and specifically the '[Muscle thin filament tropomyosin](/details-gene/GO:0005862)' complex further solidifies its role as a fundamental building block of the cell's mechanical machinery. ## Research Directions The established role of [TPM2](/details-gene/7169) in congenital myopathies and its widespread expression in non-muscle contractile cells provide fertile ground for future investigation. While its function in muscle is well-characterized, its specific contributions to the pathophysiology of non-muscular diseases and its role in specialized immune cells remain less explored. **Proposed Hypotheses:** 1. Given its high expression in [myofibroblast cell](/details-cell/CL0000186), [TPM2](/details-gene/7169) likely plays a critical role in the pathogenesis of fibrotic diseases. We hypothesize that specific isoforms of [TPM2](/details-gene/7169) are upregulated during myofibroblast differentiation and are essential for the generation of contractile force that leads to tissue stiffening in diseases like idiopathic pulmonary fibrosis or liver cirrhosis. 2. The unexpected high significance of [TPM2](/details-gene/7169) in [plasmacytoid dendritic cells](/details-cell/CL0001058) (pDCs) suggests a non-canonical function. We hypothesize that in pDCs, [TPM2](/details-gene/7169) is not involved in tonic contraction but instead regulates the dynamic remodeling of the actin cytoskeleton required for critical pDC functions, such as chemotactic migration to inflammatory sites or the polarized secretion of type I interferons upon viral sensing. **Experimental Approach:** To test the second hypothesis regarding the role of [TPM2](/details-gene/7169) in pDC function, one could perform loss-of-function studies. Primary human pDCs could be isolated and transfected with siRNA targeting [TPM2](/details-gene/7169]. The functional consequences of knockdown could then be assessed using multiple assays. A transwell migration assay would quantify the cells' ability to migrate towards a chemokine gradient (e.g., CXCL12). To assess its role in cytokine secretion, control and knockdown cells could be stimulated with a TLR9 agonist (CpG-A), followed by measurement of IFN-alpha production by ELISA. Finally, advanced imaging techniques like live-cell microscopy could be used to visualize actin dynamics and cell morphology during migration or upon activation. **Therapeutic Potential:** As a fundamental structural protein, [TPM2](/details-gene/7169) presents a challenging therapeutic target. The associated diseases are congenital myopathies caused by missense mutations that alter protein function, rather than simple overexpression ([Link](https://doi.org/10.1212/01.wnl.0000336654.44814.b8)). Therefore, broad inhibition or activation with small molecules is unlikely to be effective and could have significant on-target toxicity in healthy muscle and other tissues. The most promising therapeutic avenues would likely involve gene-editing or RNA-based strategies, such as allele-specific oligonucleotide therapies or CRISPR-based correction, designed to specifically target the mutant allele while preserving the function of the wild-type copy.

Genular Protein ID: 3449325580

Symbol: TPM2_HUMAN

Name: Tropomyosin beta chain

UniProtKB Accession Codes:

Database IDs:

Citations:

PubMed ID: 3865200

Title: A muscle-type tropomyosin in human fibroblasts: evidence for expression by an alternative RNA splicing mechanism.

PubMed ID: 3865200

DOI: 10.1073/pnas.82.23.7835

PubMed ID: 3368322

Title: Complete nucleotide sequence of the adult skeletal isoform of human skeletal muscle beta-tropomyosin.

PubMed ID: 3368322

DOI: 10.1093/nar/16.7.3109

PubMed ID: 2059197

Title: A cDNA encoding a muscle-type tropomyosin cloned from a human epithelial cell line: identity with human fibroblast tropomyosin TM1.

PubMed ID: 2059197

DOI: 10.1016/0006-291x(91)90647-p

PubMed ID: 15164053

Title: DNA sequence and analysis of human chromosome 9.

PubMed ID: 15164053

DOI: 10.1038/nature02465

PubMed ID: 15489334

Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).

PubMed ID: 15489334

DOI: 10.1101/gr.2596504

PubMed ID: 2303454

Title: A nonmuscle tropomyosin is encoded by the smooth/skeletal beta-tropomyosin gene and its RNA is transcribed from an internal promoter.

PubMed ID: 2303454

DOI: 10.1016/s0021-9258(19)39791-1

PubMed ID: 11840567

Title: Cluster analysis of an extensive human breast cancer cell line protein expression map database.

PubMed ID: 11840567

DOI: 10.1002/1615-9861(200202)2:2<212::aid-prot212>3.0.co;2-h

PubMed ID: 21269460

Title: Initial characterization of the human central proteome.

PubMed ID: 21269460

DOI: 10.1186/1752-0509-5-17

PubMed ID: 24275569

Title: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.

PubMed ID: 24275569

DOI: 10.1016/j.jprot.2013.11.014

PubMed ID: 11738357

Title: Mutations in the beta-tropomyosin (TPM2) gene -- a rare cause of nemaline myopathy.

PubMed ID: 11738357

DOI: 10.1016/s0960-8966(01)00252-8

PubMed ID: 12592607

Title: Mutations in genes encoding fast-twitch contractile proteins cause distal arthrogryposis syndromes.

PubMed ID: 12592607

DOI: 10.1086/368294

PubMed ID: 17846275

Title: Congenital myopathy with nemaline rods and cap structures caused by a mutation in the beta-tropomyosin gene (TPM2).

PubMed ID: 17846275

DOI: 10.1001/archneur.64.9.1334

PubMed ID: 17339586

Title: Distal arthrogryposis and muscle weakness associated with a beta-tropomyosin mutation.

PubMed ID: 17339586

DOI: 10.1212/01.wnl.0000256339.40667.fb

PubMed ID: 17434307

Title: Cap disease caused by heterozygous deletion of the beta-tropomyosin gene TPM2.

PubMed ID: 17434307

DOI: 10.1016/j.nmd.2007.02.015

PubMed ID: 19047562

Title: New morphologic and genetic findings in cap disease associated with beta-tropomyosin (TPM2) mutations.

PubMed ID: 19047562

DOI: 10.1212/01.wnl.0000336654.44814.b8

PubMed ID: 19345583

Title: Cap disease due to mutation of the beta-tropomyosin gene (TPM2).

PubMed ID: 19345583

DOI: 10.1016/j.nmd.2009.03.003

PubMed ID: 23678273

Title: First Korean family with a mutation in TPM2 associated with Sheldon-Hall syndrome.

PubMed ID: 23678273

DOI: 10.3346/jkms.2013.28.5.780

PubMed ID: 24692096

Title: Mutation update and genotype-phenotype correlations of novel and previously described mutations in TPM2 and TPM3 causing congenital myopathies.

PubMed ID: 24692096

DOI: 10.1002/humu.22554

PubMed ID: 30285720

Title: Novel mutations in TPM2 and PIEZO2 are responsible for distal arthrogryposis (DA) 2B and mild DA in two Chinese families.

PubMed ID: 30285720

DOI: 10.1186/s12881-018-0692-8

Sequence Information:

  • Length: 284
  • Mass: 32851
  • Checksum: 18E330568E14E0BE
  • Sequence:
  • MDAIKKKMQM LKLDKENAID RAEQAEADKK QAEDRCKQLE EEQQALQKKL KGTEDEVEKY 
    SESVKEAQEK LEQAEKKATD AEADVASLNR RIQLVEEELD RAQERLATAL QKLEEAEKAA 
    DESERGMKVI ENRAMKDEEK MELQEMQLKE AKHIAEDSDR KYEEVARKLV ILEGELERSE 
    ERAEVAESKC GDLEEELKIV TNNLKSLEAQ ADKYSTKEDK YEEEIKLLEE KLKEAETRAE 
    FAERSVAKLE KTIDDLEDEV YAQKMKYKAI SEELDNALND ITSL

Genular Protein ID: 6141089

Symbol: A7XZE4_HUMAN

Name: N/A

UniProtKB Accession Codes:

Database IDs:

Citations:

PubMed ID: 11237011

Title: Initial sequencing and analysis of the human genome.

PubMed ID: 11237011

DOI: 10.1038/35057062

PubMed ID: 15164053

Title: DNA sequence and analysis of human chromosome 9.

PubMed ID: 15164053

DOI: 10.1038/nature02465

PubMed ID: 15496913

Title: Finishing the euchromatic sequence of the human genome.

PubMed ID: 15496913

DOI: 10.1038/nature03001

PubMed ID: 21269460

Title: Initial characterization of the human central proteome.

PubMed ID: 21269460

DOI: 10.1186/1752-0509-5-17

Sequence Information:

  • Length: 284
  • Mass: 33026
  • Checksum: C1D4A215BBA197C1
  • Sequence:
  • MDAIKKKMQM LKLDKENAID RAEQAEADKK QAEDRCKQLE EEQQALQKKL KGTEDEVEKY 
    SESVKEAQEK LEQAEKKATD AEADVASLNR RIQLVEEELD RAQERLATAL QKLEEAEKAA 
    DESERGMKVI ENRAMKDEEK MELQEMQLKE AKHIAEDSDR KYEEVARKLV ILEGELERSE 
    ERAEVAESRA RQLEEELRTM DQALKSLMAS EEEYSTKEDK YEEEIKLLEE KLKEAETRAE 
    FAERSVAKLE KTIDDLEDEV YAQKMKYKAI SEELDNALND ITSL

Genular Protein ID: 3517933103

Symbol: Q5TCU3_HUMAN

Name: N/A

UniProtKB Accession Codes:

Database IDs:

Citations:

PubMed ID: 11237011

Title: Initial sequencing and analysis of the human genome.

PubMed ID: 11237011

DOI: 10.1038/35057062

PubMed ID: 15164053

Title: DNA sequence and analysis of human chromosome 9.

PubMed ID: 15164053

DOI: 10.1038/nature02465

PubMed ID: 15496913

Title: Finishing the euchromatic sequence of the human genome.

PubMed ID: 15496913

DOI: 10.1038/nature03001

PubMed ID: 21269460

Title: Initial characterization of the human central proteome.

PubMed ID: 21269460

DOI: 10.1186/1752-0509-5-17

PubMed ID: 24275569

Title: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.

PubMed ID: 24275569

DOI: 10.1016/j.jprot.2013.11.014

Sequence Information:

  • Length: 284
  • Mass: 32815
  • Checksum: 817AF2EB91639EB5
  • Sequence:
  • MDAIKKKMQM LKLDKENAID RAEQAEADKK QAEDRCKQLE EEQQALQKKL KGTEDEVEKY 
    SESVKEAQEK LEQAEKKATD AEADVASLNR RIQLVEEELD RAQERLATAL QKLEEAEKAA 
    DESERGMKVI ENRAMKDEEK MELQEMQLKE AKHIAEDSDR KYEEVARKLV ILEGELERSE 
    ERAEVAESKC GDLEEELKIV TNNLKSLEAQ ADKYSTKEDK YEEEIKLLEE KLKEAETRAE 
    FAERSVAKLE KTIDDLEETL ASAKEENVEI HQTLDQTLLE LNNL

Genular Protein ID: 476369656

Symbol: V9HW25_HUMAN

Name: N/A

UniProtKB Accession Codes:

Database IDs:

Sequence Information:

  • Length: 284
  • Mass: 32990
  • Checksum: 584D60A8A4D6E9CA
  • Sequence:
  • MDAIKKKMQM LKLDKENAID RAEQAEADKK QAEDRCKQLE EEQQALQKKL KGTEDEVEKY 
    SESVKEAQEK LEQAEKKATD AEADVASLNR RIQLVEEELD RAQERLATAL QKLEEAEKAA 
    DESERGMKVI ENRAMKDEEK MELQEMQLKE AKHIAEDSDR KYEEVARKLV ILEGELERSE 
    ERAEVAESRA RQLEEELRTM DQALKSLMAS EEEYSTKEDK YEEEIKLLEE KLKEAETRAE 
    FAERSVAKLE KTIDDLEETL ASAKEENVEI HQTLDQTLLE LNNL